AU2003272974A1 - Anti-influenza virus agent - Google Patents

Anti-influenza virus agent

Info

Publication number
AU2003272974A1
AU2003272974A1 AU2003272974A AU2003272974A AU2003272974A1 AU 2003272974 A1 AU2003272974 A1 AU 2003272974A1 AU 2003272974 A AU2003272974 A AU 2003272974A AU 2003272974 A AU2003272974 A AU 2003272974A AU 2003272974 A1 AU2003272974 A1 AU 2003272974A1
Authority
AU
Australia
Prior art keywords
influenza virus
virus agent
agent
influenza
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003272974A
Inventor
Kenji Tsunoda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of AU2003272974A1 publication Critical patent/AU2003272974A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
AU2003272974A 2002-10-11 2003-10-10 Anti-influenza virus agent Abandoned AU2003272974A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-298501 2002-10-11
JP2002298501 2002-10-11
PCT/JP2003/013049 WO2004032915A1 (en) 2002-10-11 2003-10-10 Anti-influenza virus agent

Publications (1)

Publication Number Publication Date
AU2003272974A1 true AU2003272974A1 (en) 2004-05-04

Family

ID=32089310

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003272974A Abandoned AU2003272974A1 (en) 2002-10-11 2003-10-10 Anti-influenza virus agent

Country Status (3)

Country Link
JP (1) JP4600882B2 (en)
AU (1) AU2003272974A1 (en)
WO (1) WO2004032915A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5102506B2 (en) * 2006-03-17 2012-12-19 第一三共ヘルスケア株式会社 Anti-inflammatory pharmaceutical composition
JP2007291072A (en) * 2006-03-27 2007-11-08 Daiichi Sankyo Healthcare Co Ltd Pharmaceutical composition
JP2007291067A (en) * 2006-03-29 2007-11-08 Daiichi Sankyo Healthcare Co Ltd Pharmaceutical composition
JP2008115168A (en) * 2006-10-12 2008-05-22 Daiichi Sankyo Healthcare Co Ltd Anti-adenovirus agent
JP5753435B2 (en) * 2010-04-26 2015-07-22 第一三共ヘルスケア株式会社 Anti-ulcer composition
JP2013237666A (en) * 2012-04-16 2013-11-28 Daiichi Sankyo Healthcare Co Ltd Therapeutic and/or prophylactic agent for disease associated with overwork or chronic fatigue
CN111315374A (en) * 2017-08-27 2020-06-19 抗病毒科技有限责任公司 Methods and compositions for antiviral use of synthetic lysine analogs and mimetics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3047948B2 (en) * 1992-12-07 2000-06-05 株式会社ツムラ Composition for nasal administration of peptides
WO1995033474A1 (en) * 1994-06-03 1995-12-14 Tsumura & Co. Medicinal composition
US5888518A (en) * 1995-10-06 1999-03-30 Beretich, Sr.; Guy R. Method for preventing and treating coccidiosis
JP3929618B2 (en) * 1998-09-22 2007-06-13 ロート製薬株式会社 Solid oral pharmaceutical composition for treatment of mouth-dissolving or chewing type rhinitis

Also Published As

Publication number Publication date
JP4600882B2 (en) 2010-12-22
WO2004032915A1 (en) 2004-04-22
JPWO2004032915A1 (en) 2006-02-02

Similar Documents

Publication Publication Date Title
AU2002361879A1 (en) Dependence-chain processors
AU2003220935A1 (en) Benzamide derivatives
AU2003221497A1 (en) Pharmaceutical microparticles
AU2002952384A0 (en) Structures
AU2003255831A1 (en) Delayed-gelation solution
AU2003202091A1 (en) Guanidine derivatives
AU2003220968A1 (en) Anti-inflammatory agent
AU2003272902A1 (en) Remedies
AU2003230395A1 (en) Micro-support structures
AU2003244836A1 (en) Suspending agent
AU2003212776A1 (en) Microparticles
AU2003273819A1 (en) Coating agent
AU2003292859A1 (en) Feng-you-jing spray
AU2003221395A1 (en) Plasma processor
AU2003289207A1 (en) Anti-inflammatory agent
AU2003272974A1 (en) Anti-influenza virus agent
AU2003290818A1 (en) Topoisomerase-targeting agents
AU2003272901A1 (en) Remedies
AUPS019202A0 (en) Firefighting
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2003269185A1 (en) Software protection
AU2003207181A1 (en) Microorganism-trapping agent
AU2003233751A1 (en) Scaffolding
AU2003233232A1 (en) Anti-rhinovirus active agents
AU2003236239A1 (en) Remedies

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase